Qijun Shen1,2, Yanna Shan1, Wen Xu1, Guangzhu Hu1, Wenhui Chen1, Zhan Feng3, Peipei Pang4, Zhongxiang Ding5, Wenli Cai6. 1. Department of Radiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, No. 261, Huansha Road, Zhejiang, Hangzhou, China. 2. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 25 New Chardon St., 400C, Boston, MA, 02114, USA. 3. Department of Radiology, First Affiliated Hospital, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. 4. GE Healthcare (China), Shanghai, China. 5. Department of Radiology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, No. 261, Huansha Road, Zhejiang, Hangzhou, China. hangzhoudzx73@126.com. 6. Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 25 New Chardon St., 400C, Boston, MA, 02114, USA. Cai.Wenli@mgh.harvard.edu.
Abstract
OBJECTIVES: To construct and validate a nomogram model that integrated the CT radiomic features and the TNM staging for risk stratification of thymic epithelial tumors (TETs). METHODS: A total of 136 patients with pathology-confirmed TETs who underwent CT examination were collected from two institutions. According to the WHO pathological classification criteria, patients were classified into low-risk and high-risk groups. The TNM staging was determined in terms of the 8th edition AJCC/UICC staging criteria. LASSO regression was performed to extract the optimal features correlated to risk stratification among the 704 radiomic features calculated. A nomogram model was constructed by combining the Radscore and the TNM staging. The clinical performance was evaluated by ROC analysis, calibration curve, and decision curve analysis (DCA). The Kaplan-Meier (KM) analysis was employed for survival analysis. RESULTS: Five optimal features identified by LASSO regression were employed to calculate the Radscore correlated to risk stratification. The nomogram model showed a better performance in both training cohort (AUC = 0.84, 95%CI 0.75-0.91) and external validation cohort (AUC = 0.79, 95%CI 0.69-0.88). The calibration curve and DCA analysis indicated a better accuracy of the nomogram model for risk stratification than either Radscore or the TNM staging alone. The KM analysis showed a significant difference between the two groups stratified by the nomogram model (p = 0.02). CONCLUSIONS: A nomogram model that integrated the radiomic signatures and the TNM staging could serve as a reliable model of risk stratification in predicting the prognosis of patients with TETs. KEY POINTS: • The radiomic features could be associated with the TET pathophysiology. • TNM staging and Radscore could independently stratify the risk of TETs. • The nomogram model is more objective and more comprehensive than previous methods.
OBJECTIVES: To construct and validate a nomogram model that integrated the CT radiomic features and the TNM staging for risk stratification of thymic epithelial tumors (TETs). METHODS: A total of 136 patients with pathology-confirmed TETs who underwent CT examination were collected from two institutions. According to the WHO pathological classification criteria, patients were classified into low-risk and high-risk groups. The TNM staging was determined in terms of the 8th edition AJCC/UICC staging criteria. LASSO regression was performed to extract the optimal features correlated to risk stratification among the 704 radiomic features calculated. A nomogram model was constructed by combining the Radscore and the TNM staging. The clinical performance was evaluated by ROC analysis, calibration curve, and decision curve analysis (DCA). The Kaplan-Meier (KM) analysis was employed for survival analysis. RESULTS: Five optimal features identified by LASSO regression were employed to calculate the Radscore correlated to risk stratification. The nomogram model showed a better performance in both training cohort (AUC = 0.84, 95%CI 0.75-0.91) and external validation cohort (AUC = 0.79, 95%CI 0.69-0.88). The calibration curve and DCA analysis indicated a better accuracy of the nomogram model for risk stratification than either Radscore or the TNM staging alone. The KM analysis showed a significant difference between the two groups stratified by the nomogram model (p = 0.02). CONCLUSIONS: A nomogram model that integrated the radiomic signatures and the TNM staging could serve as a reliable model of risk stratification in predicting the prognosis of patients with TETs. KEY POINTS: • The radiomic features could be associated with the TET pathophysiology. • TNM staging and Radscore could independently stratify the risk of TETs. • The nomogram model is more objective and more comprehensive than previous methods.
Authors: Kazuya Kondo; Paul Van Schil; Frank C Detterbeck; Meinoshin Okumura; Kelly Stratton; Dorothy Giroux; Hisao Asamura; John Crowley; Conrad Falkson; Pier Luigi Filosso; Giuseppe Giaccone; James Huang; Jhingook Kim; Marco Lucchi; Mirella Marino; Edith M Marom; Andrew G Nicholson; Enrico Ruffini Journal: J Thorac Oncol Date: 2014-09 Impact factor: 15.609
Authors: William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba Journal: J Thorac Oncol Date: 2015-09 Impact factor: 15.609
Authors: Pier Luigi Filosso; Enrico Ruffini; Paolo Olivo Lausi; Marco Lucchi; Alberto Oliaro; Frank Detterbeck Journal: Lung Cancer Date: 2013-10-15 Impact factor: 5.705
Authors: Frank C Detterbeck; Cesar Moran; James Huang; Saul Suster; Garrett Walsh; Lawrence Kaiser; Mark Wick Journal: Zhongguo Fei Ai Za Zhi Date: 2014-02
Authors: Chengzhou Zhang; Qinglin Yang; Fan Lin; Heng Ma; Haicheng Zhang; Ran Zhang; Ping Wang; Ning Mao Journal: Front Oncol Date: 2021-12-10 Impact factor: 6.244